Investing KRW 1 trillion in Vietnam to establish a bio butanediol plant with an annual production capacity of 200,000 tons. Building the world’s first integrated production system for bio spandex, from raw materials to finished fibers. SEOUL, South Korea, Aug. 1, 2024 /PRNewswire/ — Cho Hyun-joon, Chairman of Hyosung, has identified “Bio BDO” as the […]
Category Archives: Pr Newswire
Company Will Use New Funding to Accelerate Its Business Momentum in the EMEA Region MONTREAL and LONDON, Aug. 1, 2024 /PRNewswire/ — WorkJam, the world’s leading digital frontline workplace, has announced it has received a $20 million investment from Export Development Canada (EDC) to expand its international operations. WorkJam will use the new funding to accelerate […]
Adjusted EBITDA up 57% Year-on-Year Market Share Reached 16.5% HONG KONG, Aug 1, 2024 /PRNewswire/ — MGM China Holdings Limited (“MGM China” or the “Company”; SEHK Stock Code: 2282) today announced the selected unaudited financial data of the Company and its subsidiaries (the “Group”) for second quarter and the first half of 2024 (the “Period”). […]
AUCKLAND, New Zealand, Aug. 1, 2024 /PRNewswire/ — Engineered in the USA and built to aid adventurers taking on the toughest terrain – including mud, sand, and rocks – the Goodyear Wrangler Boulder MT leverages Goodyear’s innovation and technology to help ensure 4WD enthusiasts can take on serious off-road adventures. This new tyre was designed with […]
PALO ALTO, Calif., Aug. 1, 2024 /PRNewswire/ — Hesai Technology (Nasdaq: HSAI), the global leader in lidar solutions, today announced automotive lidar design wins with three leading global OEM’s joint ventures (JV) in China. The ventures include two U.S. automotive companies and one European automotive brand. These joint venture companies plan to integrate Hesai’s automotive-grade, […]
WALTHAM, Mass., July 31, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced the publication of plain language summaries of results from two clinical trials on XPHOZAH® (tenapanor), NORMALIZE and OPTIMIZE, in Current […]
Designation is based on results from the Phase 2 ORCA-V1 trial that showed treatment with cytisinicline more than doubled the odds of quitting e-cigarettes compared with placebo SEATTLE and VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization […]
Poster Presentation at 2024 Military Health System Research Symposium DALLAS, July 31, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced continuing progress in the development of DeepView SnapShot® M, […]
Media Release Entered into third and most important clinical trial collaboration and supply agreement to date with MSD to evaluate eftilagimod alfa (efti) in combination with KEYTRUDA® (pembrolizumab) and chemotherapy for first-line non-small cell lung cancer in a pivotal Phase III trial Continuing positive clinical data reported from efti: Positive results from TACTI-003 Phase IIb […]
EAGAN, Minn., July 31, 2024 (GLOBE NEWSWIRE) — The Blue Cross and Blue Shield of Minnesota Foundation has awarded more than $3.4M in grants to 16 nonprofit organizations in Minnesota, as part of its focus on improving access to and quality of early childhood care and education supports, particularly for vulnerable young children and their […]
